CFR section

21 CFR 606.121(c)(1): Container label

PART 606-CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS · Subpart G-Additional Labeling Standards for Blood and Blood Components

Key facts

Citation 21 CFR 606.121(c)(1)
Section Container label
Part PART 606-CURRENT GOOD MANUFACTURING PRACTICE FOR BLOOD AND BLOOD COMPONENTS
Subpart Subpart G-Additional Labeling Standards for Blood and Blood Components
Subchapter 21 CFR F Biologics
Product types cited Biologics, Drugs
Regulation text (excerpt) (1) The proper name of the product in a prominent position, with any appropriate modifiers and attributes.

At a glance

  • 1–9 Inspections citing this section
  • None Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA